Enlitenai, Inc

EnlitenAI SF Bay Area EnlitenAI is revolutionizing the personalized management of epilepsy through a device agnostic platform (Neuroliten) that uses wearable devices for remote patient monitoring and titration of treatment. EnlitenAI's monitoring platform aids seizure burden calculations, informing decisions of dose adjustment or drug substitution, potentially reducing delays in care and shortening titration cycles. In later phases, the platform will sport features pertinent to drug/dose recommendations further alleviating the “trial-and-error” problem pervasive in epilepsy management. Our long-term vision includes expanding Neuroliten to support other neurological & behavioral conditions as well.